E

embecta

Manufactures insulin delivery devices worldwide

Machine Attendant

Machine & Process OperationUpdated on Nov 15
Full-timeHoldrege, NE, USANo salary listedIn-person

About the Job

Requirements

  • A high school diploma or GED is required.
  • The employee must be able to read, write, and speak English.
  • Basic computer keyboard and navigation skills, including Microsoft Office, are required.
  • The employee must maintain certification on assigned equipment.
  • The employee must maintain regular, punctual attendance.
  • The employee must remain alert and focused in a high-speed manufacturing environment.
  • The employee must follow company policies, standards, and rules, including safety policies and lockout procedures.
  • The employee must understand and apply company standards and specifications to ensure products meet those standards.

Responsibilities

  • Maintain equipment according to the preventive maintenance schedule.
  • Clean machines and the immediate work area.
  • Produce, visually inspect, and package product.
  • Operate equipment and perform process functions.
  • Conduct inspections and perform process tests.
  • Complete required paperwork in a timely manner.
  • Respond to and reset alarms as needed.
  • Contribute to a productive work environment through communication with team members.
  • Contribute to continuous process improvement.
  • Maintain a clean and safe work environment.
  • Perform other duties assigned by the Shift Leader to support business needs.

Desired Qualifications

  • At least one year of experience working in a manufacturing environment and/or experience working for BD or embecta.
  • Good interpersonal skills.

About the Company

embecta

Manufactures insulin delivery devices worldwide

Embecta designs, manufactures, and sells insulin delivery devices such as pen needles, insulin syringes, and safety injection devices for diabetes patients around the world. Its products are used to inject insulin and include disposable components like Nano and Ultra-Fine needles, with a tubeless insulin patch pump once pursued but later refocused on core injection devices. The company differentiates itself as a dedicated diabetes injection devices supplier with a global manufacturing footprint and an established distribution network, originating as a BD spin-off. Embecta aims to grow through strategic expansion, including an announced plan to acquire Owen Mumford to broaden into drug-delivery platforms beyond diabetes.

Company size
1,001-5,000
Company stage
Not listed
Total funding
Not listed
Headquarters
Parsippany-Troy Hills, NJ
Founded
2022

Recently Posted Jobs

Explore more opportunities at embecta

See more jobs